KENILWORTH, N.J. & MIAMI — Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced data from six preclinical studies demonstrating that molnupiravir,… Read More
VANCOUVER, B.C. — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has received… Read More
The positive opinion is based on the landmark EMPEROR-Preserved Phase III trial, which showed significant outcomes in patients with heart failure with left ventricular ejection fraction over 40%1 If approved,… Read More
Health Canada list identifies select companies that can supply psilocybin to approved applicants through the Special Access Program for patient treatment VANCOUVER, B.C. – Numinus Wellness Inc. (“Numinus” or the… Read More
Announcing our 2022 competition suite Our 2022 funding competition lineup provides opportunities for BC health researchers across all regions of the province. These competitions reflect rigorous program evaluation; collection of robust… Read More
